Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.

about

Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.

Item

http://www.wikidata.org/entity/Q36734707

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Factors Influencing Non-sentin ...... dian Breast Cancer Population.

@ast

Factors Influencing Non-sentin ...... dian Breast Cancer Population.

@en

type

Item

label

Factors Influencing Non-sentin ...... dian Breast Cancer Population.

@ast

Factors Influencing Non-sentin ...... dian Breast Cancer Population.

@en

prefLabel

Factors Influencing Non-sentin ...... dian Breast Cancer Population.

@ast

Factors Influencing Non-sentin ...... dian Breast Cancer Population.

@en

P1476

Factors Influencing Non-sentin ...... ndian Breast Cancer Population

@en

P2093

Ann Kurien

http://www.w3.org/2001/XMLSchema#string

Khadher Hussain

http://www.w3.org/2001/XMLSchema#string

Muhamed Faizal Ayub

http://www.w3.org/2001/XMLSchema#string

Selvi Radhakrishna

http://www.w3.org/2001/XMLSchema#string

P2860

New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.

Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?

Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.

Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.

Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations.

Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.

Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement.

P2888

s13193-015-0431-y

P304

337-345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13193-015-0431-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Naveen Padmanabhan

P577

2015-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285782356

http://www.w3.org/2001/XMLSchema#string

P698

27065658

http://www.w3.org/2001/XMLSchema#string

P932

4809847

http://www.w3.org/2001/XMLSchema#string